Low-dose penicillin exposure in early life decreases Th17 and the susceptibility to DSS colitis in mice through gut microbiota modification

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Jin, Shuang ^a   Zhao, Di ^a   Cai, Chenwen ^a   Song, Dongjuan ^a   Shen, Jun ^a   Xu, Antao ^a   Qiao, Yuqi ^a   Ran, Zhihua ^a   Zheng, Qing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DEXTRAN SULFATE; INTERLEUKIN 17; PENICILLIN DERIVATIVE;

ANIMAL; BACTERIUM; BIODIVERSITY; CELL DIFFERENTIATION; CLASSIFICATION; COLITIS; DISEASE MODEL; DISEASE PREDISPOSITION; DOSE RESPONSE; DRUG EFFECT; FECES; GENE EXPRESSION; GENETICS; IMMUNOLOGY; INTESTINE FLORA; LYMPHOCYTE COUNT; MALE; METABOLISM; MICROBIOLOGY; MOUSE; PATHOLOGY; TH17 CELL;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BIODIVERSITY; CELL DIFFERENTIATION; COLITIS; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; DOSE-RESPONSE RELATIONSHIP, DRUG; FECES; GASTROINTESTINAL MICROBIOME; GENE EXPRESSION; INTERLEUKIN-17; LYMPHOCYTE COUNT; MALE; MICE; PENICILLINS; TH17 CELLS;

EID: 85014933257     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep43662     Document Type: Article

References (64)

1. Kaplan, G. G. The global burden of IBD: from 2015 to 2025. Nature reviews. Gastroenterology, & hepatology 12, 720-727 (2015
2. Ananthakrishnan, A. N. Epidemiology and risk factors for IBD. Nature reviews. Gastroenterology, & hepatology 12, 205-217 (2015
3. Ungaro, R., et al. Antibiotics associated with increased risk of new-onset Crohn's disease but not ulcerative colitis: a meta-analysis. The American journal of gastroenterology 109, 1728-1738 (2014
4. Ng, S. C., et al. Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific. Gut 64, 1063-1071 (2015
5. Ko, Y., et al. Inflammatory Bowel Disease Environmental Risk Factors: A Population-Based Case-Control Study of Middle Eastern Migration to Australia. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association 13, 1453-1463 (2015
6. Hviid, A., Svanstrom, H., & Frisch, M. Antibiotic use and inflammatory bowel diseases in childhood. Gut 60, 49-54 (2011
7. Shreiner, A. B., Kao, J. Y., & Young, V. B. The gut microbiome in health and in disease. Current opinion in gastroenterology 31, 69-75 (2015
8. Perez-Cobas, A. E., et al. Gut microbiota disturbance during antibiotic therapy: a multi-omic approach. Gut 62, 1591-1601, (2013
9. Yin, J., et al. Different Dynamic Patterns of beta-Lactams, Quinolones, Glycopeptides and Macrolides on Mouse Gut Microbial Diversity. PloS one 10, e0126712 (2015
10. Morgun, A., et al. Uncovering effects of antibiotics on the host and microbiota using transkingdom gene networks. Gut 64, 1732-1743 (2015
11. Xu, D., et al. Rifaximin alters intestinal bacteria and prevents stress-induced gut inflammation and visceral hyperalgesia in rats. Gastroenterology 146, 484-496 (2014
12. Cox, L. M., et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 158, 705-721 (2014
13. Hao, R., Zhao, R., Qiu, S., Wang, L., & Song, H. Antibiotics crisis in China. Science (New York, N.Y.) 348, 1100-1101 (2015
14. Wang, H., et al. Antibiotic body burden of Chinese school children: a multisite biomonitoring-based study. Environmental science, & technology 49, 5070-5079 (2015
15. Vangay, P., Ward, T., Gerber, J. S., & Knights, D. Antibiotics, pediatric dysbiosis, and disease. Cell host, & microbe 17, 553-564 (2015
16. Ivanov, I. I., et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell host, & microbe 4, 337-349 (2008
17. Farkas, A. M., et al. Induction of Th17 cells by segmented filamentous bacteria in the murine intestine. Journal of immunological methods 421, 104-111 (2015
18. Rolig, A. S., Parthasarathy, R., Burns, A. R., Bohannan, B. J., & Guillemin, K. Individual Members of the Microbiota Disproportionately Modulate Host Innate Immune Responses. Cell host, & microbe 18, 613-620 (2015
19. Segata, N., et al. Metagenomic biomarker discovery and explanation. Genome biology 12, R60 (2011
20. Said, H. S., et al. Dysbiosis of salivary microbiota in inflammatory bowel disease and its association with oral immunological biomarkers. DNA research: an international journal for rapid publication of reports on genes and genomes 21, 15-25 (2014
21. Dziarski, R., Park, S. Y., Kashyap, D. R., Dowd, S. E., & Gupta, D. Pglyrp-Regulated Gut Microflora Prevotella falsenii, Parabacteroides distasonis and Bacteroides eggerthii Enhance and Alistipes finegoldii Attenuates Colitis in Mice. PloS one 11, e0146162 (2016
22. Scher, J. U., et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. eLife 2, e01202 (2013
23. Palm, N. W., et al. Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease. Cell 158, 1000-1010 (2014
24. Schnupf, P., Gaboriau-Routhiau, V., & Cerf-Bensussan, N. Host interactions with Segmented Filamentous Bacteria: an unusual trade-off that drives the post-natal maturation of the gut immune system. Seminars in immunology 25, 342-351 (2013
25. Gaboriau-Routhiau, V., et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 31, 677-689 (2009
26. Schnupf, P., et al. Growth and host interaction of mouse segmented filamentous bacteria in vitro. Nature 520, 99-103 (2015
27. Yin, Y., et al. Comparative analysis of the distribution of segmented filamentous bacteria in humans, mice and chickens. The ISME journal 7, 615-621 (2013
28. Sano, T., et al. An IL-23R/IL-22 Circuit Regulates Epithelial Serum Amyloid A to Promote Local Effector Th17 Responses. Cell 163, 381-393 (2015
29. Atarashi, K., et al. Th17 Cell Induction by Adhesion of Microbes to Intestinal Epithelial Cells. Cell 163, 367-380 (2015
30. Kotwani, A., & Holloway, K. Trends in antibiotic use among outpatients in New Delhi, India. BMC infectious diseases 11, 99 (2011
31. Dumartin, C., et al. Antibiotic use in 530 French hospitals: results from a surveillance network at hospital and ward levels in 2007. The Journal of antimicrobial chemotherapy 65, 2028-2036 (2010
32. Muller-Pebody, B., et al. Increase and change in pattern of hospital antimicrobial use, Denmark, 1997-2001. The Journal of antimicrobial chemotherapy 54, 1122-1126 (2004
33. Zhang, D., et al. Neutrophil ageing is regulated by the microbiome. Nature 525, 528-532 (2015
34. McGovern, D. P., Kugathasan, S., & Cho, J. H. Genetics of Inflammatory Bowel Diseases. Gastroenterology 149, 1163-1176 (2015
35. Ng, S. C., et al. Geographical variability and environmental risk factors in inflammatory bowel disease. Gut 62, 630-649 (2013
36. De Cruz, P., et al. Characterization of the Gastrointestinal Microbiota in Health and Inflammatory Bowel Disease. Inflammatory bowel diseases 18, 372-390 (2012
37. Davis, C. P., & Savage, D. C. Habitat, succession, attachment, and morphology of segmented, filamentous microbes indigenous to the murine gastrointestinal tract. Infection and immunity 10, 948-956 (1974
38. Kuwahara, T., et al. The lifestyle of the segmented filamentous bacterium: a non-culturable gut-associated immunostimulating microbe inferred by whole-genome sequencing. DNA research: an international journal for rapid publication of reports on genes and genomes 18, 291-303 (2011
39. Davis, C. P., & Savage, D. C. Effect of penicillin on the succession, attachment, and morphology of segmented, filamentous microbes in the murine small bowel. Infection and immunity 13, 180-188 (1976
40. Lee, Y. K., Menezes, J. S., Umesaki, Y., & Mazmanian, S. K. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences of the United States of America 108 Suppl 1, 4615-4622 (2011
41. Lee, H., et al. Gut-residing Microbes Alter the Host Susceptibility to Autoantibody-mediated Arthritis. Immune network 14, 38-44 (2014
42. Stepankova, R., et al. Segmented filamentous bacteria in a defined bacterial cocktail induce intestinal inflammation in SCID mice reconstituted with CD45RBhigh CD4+ T cells. Inflammatory bowel diseases 13, 1202-1211 (2007
43. Caselli, M., Tosini, D., Gafa, R., Gasbarrini, A., & Lanza, G. Segmented filamentous bacteria-like organisms in histological slides of ileo-cecal valves in patients with ulcerative colitis. The American journal of gastroenterology 108, 860-861 (2013
44. Rodriguez-Palacios, A., et al. Stereomicroscopic 3D-pattern profiling of murine and human intestinal inflammation reveals unique structural phenotypes. Nature Communications 6, 7577 (2015
45. Jostins, L., et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119-124 (2012
46. Peters, A., Lee, Y., & Kuchroo, V. K. The many faces of Th17 cells. Current opinion in immunology 23, 702-706 (2011
47. Liu, J. Z., et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nature genetics 47, 979-986 (2015
48. Wedebye Schmidt, E. G., et al. TH17 cell induction and effects of IL-17A and IL-17F blockade in experimental colitis. Inflammatory bowel diseases 19, 1567-1576, doi: 10.1097/MIB.0b013e318286fa1c (2013
49. Lochner, M., et al. Microbiota-induced tertiary lymphoid tissues aggravate inflammatory disease in the absence of RORgamma t and LTi cells. The Journal of experimental medicine 208, 125-134 (2011
50. Hueber, W., et al. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut 61, 1693-1700 (2012
51. Herrlinger, K. R., et al. Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: the ENTRANCE study. Journal of Crohn's, & colitis 7, 636-643 (2013
52. Sandborn, W. J., et al. Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis. The New England journal of medicine 367, 616-624 (2012
53. Fitzpatrick, L. R. Inhibition of IL-17 as a pharmacological approach for IBD. International reviews of immunology 32, 544-555 (2013
54. Pelletier, M., et al. Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 115, 335-343 (2010
55. Cho, I., et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 488, 621-626 (2012
56. Yanrui, D., Yujie, C., Peidong, S., & Qijun, P. Study of factors on penicillin G anion state stability. Chinese Journal of Antibiotics 28, 6-9 (2003
57. Yinbao, W., Xindi, L., Zhisan, W., Zhangliu, C., & Yang, Z. Hydrolysis characteristics of enrofloxacin. Chin. J. Appl. Ecol 17, 1086-1090 (2006
58. Bo, W., Ting, Z., Jinxia, L., & Huaixia, C. Photodegradation of metronidazole under solar irradiation. Journal of Hubei University (Natural Science Edition) 34, 271-275 (2012
59. Wirtz, S., Neufert, C., Weigmann, B., & Neurath, M. F. Chemically induced mouse models of intestinal inflammation. Nature protocols 2, 541-546 (2007
60. Chassaing, B., et al. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature 519, 92-96 (2015
61. Caporaso, J. G., et al. QIIME allows analysis of high-throughput community sequencing data. Nature methods 7, 335-336 (2010
62. Edgar, R. C. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nature methods 10, 996-998 (2013
63. Wang, Q., Garrity, G. M., Tiedje, J. M., & Cole, J. R. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Applied and environmental microbiology 73, 5261-5267 (2007
64. Quast, C., et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic acids research 41, D590-596 (2013